NDC 58809-829

Escavite D

.beta.-carotene, Ascorbic Acid, Cholecalciferol, .alpha.-tocopherol, Dl-, Thiamine Hydrochloride, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Hydroxocobalamin, Biotin, Calcium Pantothenate, Ferrous Cysteine Glycinate, Magnesium Oxide, Zinc Oxide, Cupric Oxide, And Sodium Fluoride

Escavite D is a Oral Tablet, Chewable in the Human Prescription Drug category. It is labeled and distributed by Gm Pharmaceuticals, Inc. The primary component is .beta.-carotene; Ascorbic Acid; Cholecalciferol; .alpha.-tocopherol, Dl-; Thiamine Hydrochloride; Riboflavin; Niacin; Pyridoxine Hydrochloride; Folic Acid; Hydroxocobalamin; Biotin; Calcium Pantothenate; Ferrous Cysteine Glycinate; Magnesium Oxide; Zinc Oxide; Cupric Oxide; Sodium Fluoride.

Product ID58809-829_29e5426d-063b-4a87-80eb-8ba62c05478b
NDC58809-829
Product TypeHuman Prescription Drug
Proprietary NameEscavite D
Generic Name.beta.-carotene, Ascorbic Acid, Cholecalciferol, .alpha.-tocopherol, Dl-, Thiamine Hydrochloride, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Hydroxocobalamin, Biotin, Calcium Pantothenate, Ferrous Cysteine Glycinate, Magnesium Oxide, Zinc Oxide, Cupric Oxide, And Sodium Fluoride
Dosage FormTablet, Chewable
Route of AdministrationORAL
Marketing Start Date2014-03-03
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameGM Pharmaceuticals, INC
Substance Name.BETA.-CAROTENE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL, DL-; THIAMINE HYDROCHLORIDE; RIBOFLAVIN; NIACIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; HYDROXOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENATE; FERROUS CYSTEINE GLYCINATE; MAGNESIUM OXIDE; ZINC OXIDE; CUPRIC OXIDE; SODIUM FLUORIDE
Active Ingredient Strength2500 [iU]/1; mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Pharm ClassesVitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Antidote [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 58809-829-60

60 TABLET, CHEWABLE in 1 BOTTLE (58809-829-60)
Marketing Start Date2014-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58809-829-60 [58809082960]

Escavite D TABLET, CHEWABLE
Marketing CategoryUNAPPROVED DRUG OTHER
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-03-03
Marketing End Date2018-11-01

Drug Details

Active Ingredients

IngredientStrength
.BETA.-CAROTENE2500 [iU]/1

OpenFDA Data

SPL SET ID:8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf
Manufacturer
UNII

Pharmacological Class

  • Vitamin C [EPC]
  • Ascorbic Acid [CS]
  • Vitamin D [CS]
  • Vitamin D [EPC]
  • Nicotinic Acid [EPC]
  • Nicotinic Acids [CS]
  • Vitamin B6 Analog [EPC]
  • Vitamin B 6 [Chemical/Ingredient]
  • Analogs/Derivatives [Chemical/Ingredient]
  • Antidote [EPC]
  • Calculi Dissolution Agent [EPC]
  • Magnesium Ion Exchange Activity [MoA]
  • Osmotic Laxative [EPC]
  • Osmotic Activity [MoA]
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
  • Increased Large Intestinal Motility [PE]
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]

Medicade Reported Pricing

58809082960 ESCAVITE D TABLET CHEWABLE

Pricing Unit: EA | Drug Type:

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.